Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920300's PB Ratio is ranked worse than 80% of 2985
companies
in the Industrial Products industry
Industry Median: 2.19
vs BJSE:920300: 5.07
During the past 12 months, Shanghai Chenguang Medical Technologies Co's average Book Value Per Share Growth Rate was -26.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -0.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Chenguang Medical Technologies Co was 56.60% per year. The lowest was -18.00% per year. And the median was 15.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai Chenguang Medical Technologies Co PB Ratio Related Terms
Shanghai Chenguang Medical Technologies Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Chenguang Medical Technologies Co PB Ratio Chart
Shanghai Chenguang Medical Technologies Co Annual Data
For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Chenguang Medical Technologies Co PB Ratio vs Industrial Products Industry
Shanghai Chenguang Medical Technologies Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai Chenguang Medical Technologies Co (BJSE:920300) has a PB Ratio of 5.07 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. This is 25% above median its historical median of 4.06. Over the past decade, Shanghai Chenguang Medical Technologies Co's PB Ratio has ranged from 1.67 to 8.56. According to the industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #2388 out of 2985 companies in the Industrial Products industry, placing it in the top 80%.
Is Shanghai Chenguang Medical Technologies Co's PB Ratio too high?
Shanghai Chenguang Medical Technologies Co's current PB Ratio of 5.07 is 25% above median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 8.56. The Industrial Products industry median PB Ratio is 2.19. Shanghai Chenguang Medical Technologies Co's value of 5.07 is 131.5% above this industry median. Based on the distribution chart, Shanghai Chenguang Medical Technologies Co ranks #2388 out of 2985 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Shanghai Chenguang Medical Technologies Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Chenguang Medical Technologies Co's PB Ratio compare to VRT and BE?
According to the Industrial Products industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #2388 out of 2985 companies for PB Ratio. This places Shanghai Chenguang Medical Technologies Co in the lower half of its industry. The industry median PB Ratio is 2.19. Shanghai Chenguang Medical Technologies Co's value of 5.07 is 131.5% above this benchmark. Historically, Shanghai Chenguang Medical Technologies Co's own PB Ratio has ranged from 1.67 to 8.56 over the past decade. While the company's 10-year median is 4.06 vs. the industry median of 2.19, Shanghai Chenguang Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Industrial Products company?
The median PB Ratio among Industrial Products companies is 2.19, based on 2,985 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Chenguang Medical Technologies Co's current PB Ratio of 5.07 is 131.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. For the Industrial Products industry, the median PB Ratio is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Chenguang Medical Technologies Co's current PB Ratio is 5.07, which is 25% above median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Chenguang Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co (BJSE:920300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥9.47 — trading 44.1% above its estimated fair value. The current PB Ratio is 5.07, which is 25% above median its 10-year median of 4.06 and 131.5% above the Industrial Products industry median of 2.19. Shanghai Chenguang Medical Technologies Co's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Chenguang Medical Technologies Co (BJSE:920300), the current PB Ratio is 5.07 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued.
The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57.
GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.
Key valuation signals for BJSE:920300:
PB Ratio: 5.07 (25% above median its 10-year median of 4.06)
GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
Industry Position: 131.5% above the Industrial Products median (#2388 of 2985)
No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score
Get the complete analysis for BJSE:920300
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920300 has been successfully added to your 
